Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62K Hold
100
﹤0.01% 3842
2026
Q1
$3.31K Hold
100
﹤0.01% 3761
2025
Q4
$3.27K Hold
100
﹤0.01% 3634
2025
Q3
$1.78K Buy
+100
New +$1.45K ﹤0.01% 3745
2025
Q2
Sell
-106
Closed -$1.39K 3493
2025
Q1
$1.96K Hold
106
﹤0.01% 3152
2024
Q4
$1.75K Buy
106
+6
+6% +$85 ﹤0.01% 3150
2024
Q3
$1.4K Hold
100
﹤0.01% 3012
2024
Q2
$724 Hold
100
﹤0.01% 3039
2024
Q1
$807 Hold
100
﹤0.01% 2895
2023
Q4
$683 Hold
100
﹤0.01% 2849
2023
Q3
$500 Hold
100
﹤0.01% 3108
2023
Q2
$913 Hold
100
﹤0.01% 3096
2023
Q1
$4.96K Hold
100
﹤0.01% 2567
2022
Q4
$5K Hold
100
﹤0.01% 3758
2022
Q3
$5K Hold
100
﹤0.01% 3997
2022
Q2
$5K Hold
100
﹤0.01% 3752
2022
Q1
$5K Buy
+100
New +$864 ﹤0.01% 3752
2019
Q1
Sell
-6
Closed 2429
2018
Q4
$0 Hold
6
﹤0.01% 3527
2018
Q3
$0 Sell
6
-13,985
-100% -$610K ﹤0.01% 3818
2018
Q2
$703K Buy
+13,991
New +$616K 0.03% 542

Other funds holding AXGN

IFP Advisors's AXGN Position: Q2 2026 in Review

IFP Advisors held its Axogen (AXGN) position steady in Q2 2026 at 100 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

IFP Advisors first reported a position in AXGN in Q2 2018 and has held it in 20 quarters since. The position peaked at $703K in Q2 2018. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • IFP Advisors held 100 shares of Axogen worth $4.62K as of Q2 2026.
  • IFP Advisors left its Axogen share count unchanged in Q2 2026.
  • Axogen made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3842 holding.
  • IFP Advisors first reported a position in Axogen in Q2 2018 and has held it in 20 quarters since.
  • IFP Advisors's Axogen position peaked at $703K in Q2 2018.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.